HRA011110
Title:
Biomarker Identification for Predicting Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
Release date:
2025-11-03
Description:
We performed comprehensive transcriptomic profiling of tumor tissues from NACT-treated patients, stratified as responders (TRG0, 1, indicating complete or near-complete pathological response) and non-responders (TRG2, 3,indicating partial or minimal response), aiming to identify biomarkers associated with chemotherapy sensitivity and resistance in ESCC.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cohort Study
Disease name:
esophageal carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
China-US Hormel Cancer Institute
Contact person:
Li Xiang
Email:
xli@hci-cn.org
Description:
DAC for the project "Discovered biomarkers for predicting esophageal squamous precancerous lesions to cancer transition"
Individuals & samples
Submitter:   Li Xiang / xli@hci-cn.org
Organization:   China-US (Henan) Hormel Cancer Institute
Submission date:   2025-04-14
Requests:   -